OTCMKTS:DGNOF

DIAGNOS Stock Forecast, Price & News

$0.45

0.00 (0.00 %)

(As of 06/18/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.45

▼

$0.45

50-Day Range

$0.38

▼

$0.49

52-Week Range

$0.10

▼

$0.57

VolumeN/A

Average Volume6,539 shs

Market Capitalization$30.04 million

P/E RatioN/A

Dividend YieldN/A

Beta1.22

30 days | 90 days | 365 days | Advanced Chart

Receive DGNOF News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

About DIAGNOS

DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Kenya, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. It offers image analysis services through Computer Assisted Retinal Analysis, a software tool that assists health specialists in the detection of diabetic retinopathy. The company was founded in 1998 and is headquartered in Brossard, Canada.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Private households
Sub-IndustryN/A
SectorBusiness Services
Current SymbolOTCMKTS:DGNOF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.diagnos.ca
Phone450 678 8882
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$250,000.00
Price / Sales120.14
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.02 per share
Price / Book22.32

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares67,300,000
Market Cap$30.04 million
Next Earnings Date6/18/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Business Services Sector

498th out of 505 stocks

Private Households Industry

380th out of 381 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for DIAGNOS.

0.0 Community Rank

Outperform Votes
DIAGNOS has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
DIAGNOS has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about DIAGNOS and other stocks. Vote “Outperform” if you believe DGNOF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DGNOF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
DIAGNOS does not currently pay a dividend.
Dividend Growth
DIAGNOS does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, DIAGNOS insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of DIAGNOS is -11.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of DIAGNOS is -11.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
DIAGNOS has a P/B Ratio of 22.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

DIAGNOS (OTCMKTS:DGNOF) Frequently Asked Questions

What stocks does MarketBeat like better than DIAGNOS?

Wall Street analysts have given DIAGNOS a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DIAGNOS wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is DIAGNOS's next earnings date?

DIAGNOS is scheduled to release its next quarterly earnings announcement on Friday, June 18th 2021.
View our earnings forecast for DIAGNOS.

Who are DIAGNOS's key executives?

DIAGNOS's management team includes the following people:

Mr. Andre Larente, CEO, Pres & Exec. Director
Mr. Guillermo Moreno Robles, VP of Sales

Who are some of DIAGNOS's key competitors?

Some companies that are related to DIAGNOS include MDxHealth (MXDHF), Ted Baker (TBAKF), Carillion (CIOIF), Parkson Retail Group (PKSGY), Thomas Cook Group (TCKGY), Adocia (ADOCY), Wentworth Resource (WENTF), Reliq Health Technologies (RQHTF), Wirecard (WCAGY), ReNeuron Group (RNUGF), Hidili Industry International Development (HIIDY), Orosur Mining (OROXF), WHITE ENERGY CO/S (WECFY), Avivagen (VIVXF) and Liquefied Natural Gas (LNGLY).
View all of DGNOF's competitors.

What is DIAGNOS's stock symbol?

DIAGNOS trades on the OTCMKTS under the ticker symbol "DGNOF."

How do I buy shares of DIAGNOS?

Shares of DGNOF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DIAGNOS's stock price today?

One share of DGNOF stock can currently be purchased for approximately $0.45.

How much money does DIAGNOS make?

DIAGNOS has a market capitalization of $30.04 million and generates $250,000.00 in revenue each year.

What is DIAGNOS's official website?

The official website for DIAGNOS is www.diagnos.ca.

Where are DIAGNOS's headquarters?

DIAGNOS is headquartered at 7005 Taschereau Boulevard Suite 340, Brossard A8, J4Z 1A7.

How can I contact DIAGNOS?

DIAGNOS's mailing address is 7005 Taschereau Boulevard Suite 340, Brossard A8, J4Z 1A7. The company can be reached via phone at 450 678 8882.

This page was last updated on 6/18/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

DIAGNOS Stock Forecast, Price & News

About DIAGNOS

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Book Value per Share Ratio